ArticleGynecologic oncology reports2021

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer.

Alessandra Vultaggio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.